Health Canada approves NEUPRO® (rotigotine) patch for treatment of … – SYS-CON Media (press release)

by admin on April 7, 2013

Health Canada approves NEUPRO® (rotigotine) patch for treatment of
SYS-CON Media (press release)
The effectiveness of NEUPRO® in the treatment of Restless Legs Syndrome (RLS) was evaluated in two fixed-dose, randomized, double-blind, placebo-controlled phase 3 trials with maintenance periods of 6 months duration. Patients received NEUPRO®

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: